Cargando…

On the Use of Surface Plasmon Resonance Biosensing to Understand IgG-FcγR Interactions

Surface plasmon resonance (SPR)-based optical biosensors offer real-time and label-free analysis of protein interactions, which has extensively contributed to the discovery and development of therapeutic monoclonal antibodies (mAbs). As the biopharmaceutical market for these biologics and their bios...

Descripción completa

Detalles Bibliográficos
Autores principales: Forest-Nault, Catherine, Gaudreault, Jimmy, Henry, Olivier, Durocher, Yves, De Crescenzo, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235063/
https://www.ncbi.nlm.nih.gov/pubmed/34205578
http://dx.doi.org/10.3390/ijms22126616
_version_ 1783714229037039616
author Forest-Nault, Catherine
Gaudreault, Jimmy
Henry, Olivier
Durocher, Yves
De Crescenzo, Gregory
author_facet Forest-Nault, Catherine
Gaudreault, Jimmy
Henry, Olivier
Durocher, Yves
De Crescenzo, Gregory
author_sort Forest-Nault, Catherine
collection PubMed
description Surface plasmon resonance (SPR)-based optical biosensors offer real-time and label-free analysis of protein interactions, which has extensively contributed to the discovery and development of therapeutic monoclonal antibodies (mAbs). As the biopharmaceutical market for these biologics and their biosimilars is rapidly growing, the role of SPR biosensors in drug discovery and quality assessment is becoming increasingly prominent. One of the critical quality attributes of mAbs is the N-glycosylation of their Fc region. Other than providing stability to the antibody, the Fc N-glycosylation influences immunoglobulin G (IgG) interactions with the Fcγ receptors (FcγRs), modulating the immune response. Over the past two decades, several studies have relied on SPR-based assays to characterize the influence of N-glycosylation upon the IgG-FcγR interactions. While these studies have unveiled key information, many conclusions are still debated in the literature. These discrepancies can be, in part, attributed to the design of the reported SPR-based assays as well as the methodology applied to SPR data analysis. In fact, the SPR biosensor best practices have evolved over the years, and several biases have been pointed out in the development of experimental SPR protocols. In parallel, newly developed algorithms and data analysis methods now allow taking into consideration complex biomolecular kinetics. In this review, we detail the use of different SPR biosensing approaches for characterizing the IgG-FcγR interactions, highlighting their merit and inherent experimental complexity. Furthermore, we review the latest SPR-derived conclusions on the influence of the N-glycosylation upon the IgG-FcγR interactions and underline the differences and similarities across the literature. Finally, we explore new avenues taking advantage of novel computational analysis of SPR results as well as the latest strategies to control the glycoprofile of mAbs during production, which could lead to a better understanding and modelling of the IgG-FcγRs interactions.
format Online
Article
Text
id pubmed-8235063
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82350632021-06-27 On the Use of Surface Plasmon Resonance Biosensing to Understand IgG-FcγR Interactions Forest-Nault, Catherine Gaudreault, Jimmy Henry, Olivier Durocher, Yves De Crescenzo, Gregory Int J Mol Sci Review Surface plasmon resonance (SPR)-based optical biosensors offer real-time and label-free analysis of protein interactions, which has extensively contributed to the discovery and development of therapeutic monoclonal antibodies (mAbs). As the biopharmaceutical market for these biologics and their biosimilars is rapidly growing, the role of SPR biosensors in drug discovery and quality assessment is becoming increasingly prominent. One of the critical quality attributes of mAbs is the N-glycosylation of their Fc region. Other than providing stability to the antibody, the Fc N-glycosylation influences immunoglobulin G (IgG) interactions with the Fcγ receptors (FcγRs), modulating the immune response. Over the past two decades, several studies have relied on SPR-based assays to characterize the influence of N-glycosylation upon the IgG-FcγR interactions. While these studies have unveiled key information, many conclusions are still debated in the literature. These discrepancies can be, in part, attributed to the design of the reported SPR-based assays as well as the methodology applied to SPR data analysis. In fact, the SPR biosensor best practices have evolved over the years, and several biases have been pointed out in the development of experimental SPR protocols. In parallel, newly developed algorithms and data analysis methods now allow taking into consideration complex biomolecular kinetics. In this review, we detail the use of different SPR biosensing approaches for characterizing the IgG-FcγR interactions, highlighting their merit and inherent experimental complexity. Furthermore, we review the latest SPR-derived conclusions on the influence of the N-glycosylation upon the IgG-FcγR interactions and underline the differences and similarities across the literature. Finally, we explore new avenues taking advantage of novel computational analysis of SPR results as well as the latest strategies to control the glycoprofile of mAbs during production, which could lead to a better understanding and modelling of the IgG-FcγRs interactions. MDPI 2021-06-21 /pmc/articles/PMC8235063/ /pubmed/34205578 http://dx.doi.org/10.3390/ijms22126616 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Forest-Nault, Catherine
Gaudreault, Jimmy
Henry, Olivier
Durocher, Yves
De Crescenzo, Gregory
On the Use of Surface Plasmon Resonance Biosensing to Understand IgG-FcγR Interactions
title On the Use of Surface Plasmon Resonance Biosensing to Understand IgG-FcγR Interactions
title_full On the Use of Surface Plasmon Resonance Biosensing to Understand IgG-FcγR Interactions
title_fullStr On the Use of Surface Plasmon Resonance Biosensing to Understand IgG-FcγR Interactions
title_full_unstemmed On the Use of Surface Plasmon Resonance Biosensing to Understand IgG-FcγR Interactions
title_short On the Use of Surface Plasmon Resonance Biosensing to Understand IgG-FcγR Interactions
title_sort on the use of surface plasmon resonance biosensing to understand igg-fcγr interactions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235063/
https://www.ncbi.nlm.nih.gov/pubmed/34205578
http://dx.doi.org/10.3390/ijms22126616
work_keys_str_mv AT forestnaultcatherine ontheuseofsurfaceplasmonresonancebiosensingtounderstandiggfcgrinteractions
AT gaudreaultjimmy ontheuseofsurfaceplasmonresonancebiosensingtounderstandiggfcgrinteractions
AT henryolivier ontheuseofsurfaceplasmonresonancebiosensingtounderstandiggfcgrinteractions
AT durocheryves ontheuseofsurfaceplasmonresonancebiosensingtounderstandiggfcgrinteractions
AT decrescenzogregory ontheuseofsurfaceplasmonresonancebiosensingtounderstandiggfcgrinteractions